Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15

Alessandra Trencia1, Francesca Fiory, Maria Alessandra Maitan

  • 1Dipartimento di Biologia e Patologia Cellulare e Molecolare and Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Università degli Studi di Napoli Federico II, Naples 80131, Italy.

Insights

The pro-apoptotic Omi/HtrA2 protease degrades the anti-apoptotic PED/PEA-15 protein, promoting UVC-induced cell death. Omi/HtrA2

Area of Science:

  • Cellular and Molecular Biology
  • Apoptosis Research
  • Protein-Protein Interactions

Background:

  • PED/PEA-15 is a 15-kDa protein with broad anti-apoptotic functions.
  • Omi/HtrA2 is a mitochondrial serine protease that promotes apoptosis.
  • PED/PEA-15 and Omi/HtrA2 interactions are crucial in regulating cell death pathways.

Purpose of the Study:

  • To investigate the interaction between PED/PEA-15 and Omi/HtrA2.
  • To elucidate the role of this interaction in UVC-induced apoptosis.
  • To understand how Omi/HtrA2 affects PED/PEA-15 levels and function.

Main Methods:

  • Yeast two-hybrid screening to identify protein interactors.
  • In vitro binding assays with recombinant proteins.
  • Co-precipitation assays in cell extracts (293 and HeLa cells).
  • UVC irradiation to induce apoptosis and protein release.
  • Inhibition studies using ucf-101, a specific Omi/HtrA2 inhibitor.
  • Western blotting to assess protein expression levels and degradation.
  • Caspase activation assays and XIAP interaction studies.

Main Results:

  • Omi/HtrA2 specifically interacts with PED/PEA-15, binding both in vitro and in cell extracts.
  • UVC exposure triggers Omi/HtrA2 release from mitochondria and subsequent binding to cytoplasmic PED/PEA-15.
  • UVC-induced apoptosis leads to decreased cellular PED/PEA-15 levels, an effect inhibited by ucf-101.
  • Omi/HtrA2 directly degrades PED/PEA-15 in vitro.
  • PED/PEA-15 inhibits Omi/HtrA2-mediated apoptosis by preventing Omi/HtrA2 interaction with XIAP and subsequent caspase-3 activation.
  • The anti-apoptotic effect of PED/PEA-15 diminishes with increasing Omi/HtrA2 levels, modulated by ucf-101.

Conclusions:

  • Omi/HtrA2-mediated degradation of PED/PEA-15 is a key mechanism contributing to UVC-induced apoptosis.
  • PED/PEA-15 levels modulate Omi/HtrA2's ability to release XIAP inhibition on caspases.
  • The balance between Omi/HtrA2 and PED/PEA-15 levels dictates the cell's susceptibility to apoptosis following mitochondrial Omi/HtrA2 release.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.